128 related articles for article (PubMed ID: 31391406)
1. Plasma cell myeloma positive for t(14;20) with relapse in the central nervous system.
Murase T; Inagaki A; Masaki A; Fujii K; Narita T; Ri M; Hanamura I; Iida S; Inagaki H
J Clin Exp Hematop; 2019 Sep; 59(3):135-139. PubMed ID: 31391406
[TBL] [Abstract][Full Text] [Related]
2. The t(14;20)(q32;q12): a rare cytogenetic change in multiple myeloma associated with poor outcome.
Vekemans MC; Lemmens H; Delforge M; Doyen C; Pierre P; Demuynck H; Bries G; Lemmens J; Meeus P; Straetmans N; Bauwens D; Vidrequin S; Rack K; Vandenberghe P; Wlodarska I; Michaux L
Br J Haematol; 2010 Jun; 149(6):901-4. PubMed ID: 20148877
[No Abstract] [Full Text] [Related]
3. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
[TBL] [Abstract][Full Text] [Related]
4. A case of double-refractory multiple myeloma with both the IgH-MMSET fusion protein and the congenital abnormality t(11;22).
Suzuki R; Warita T; Nakamura Y; Kitamura Y; Aoyama Y; Ogawa Y; Kawada H; Ando K
Int J Hematol; 2019 Jun; 109(6):731-736. PubMed ID: 30680670
[TBL] [Abstract][Full Text] [Related]
5. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
[TBL] [Abstract][Full Text] [Related]
6. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
[TBL] [Abstract][Full Text] [Related]
7. Light-chain plasma cell myeloma caused by 14q32/IGH translocation and loss of the other allele.
Nishio Y; Sakai H; Saiki Y; Uchida A; Uemura Y; Matsunawa M; Isobe Y; Kato M; Tomita N; Miura I
Int J Hematol; 2019 May; 109(5):572-577. PubMed ID: 30887274
[TBL] [Abstract][Full Text] [Related]
8. Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort.
Jelinek T; Popkova T; Duras J; Mihalyova J; Kascak M; Benkova K; Plonkova H; Cerna L; Koristek Z; Simicek M; Hajek R
Hematol Oncol; 2020 Aug; 38(3):412-414. PubMed ID: 32323881
[No Abstract] [Full Text] [Related]
9. MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients.
Stralen E; Leguit RJ; Begthel H; Michaux L; Buijs A; Lemmens H; Scheiff JM; Doyen C; Pierre P; Forget F; Clevers HC; Bast B
Leukemia; 2009 Apr; 23(4):801-3. PubMed ID: 18830254
[No Abstract] [Full Text] [Related]
10. Bortezomib-based induction improves progression-free survival of myeloma patients harboring 17p deletion and/or t(4;14) and overcomes their adverse prognosis.
El-Ghammaz AM; Abdelwahed E
Ann Hematol; 2016 Aug; 95(8):1315-21. PubMed ID: 27184486
[TBL] [Abstract][Full Text] [Related]
11. A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report.
Gozzetti A; Cerase A; Crupi R; Raspadori D; Defina M; Bocchia M; Lauria F
Leuk Res; 2011 Nov; 35(11):e206-8. PubMed ID: 21767877
[No Abstract] [Full Text] [Related]
12. Cytogenetic Study and Analysis of Protein Expression in Plasma Cell Myeloma with t(11;14)(q13;q32): Absence of BCL6 and SOX11, and Infrequent Expression of CD20 and PAX5.
Yokoi S; Sakai H; Uchida A; Uemura Y; Sato K; Tsuruoka Y; Nishio Y; Matsunawa M; Suzuki Y; Isobe Y; Kato M; Inoue Y; Hoshikawa M; Miura I
J Clin Exp Hematop; 2015; 55(3):137-43. PubMed ID: 26763361
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases.
Fonseca R; Witzig TE; Gertz MA; Kyle RA; Hoyer JD; Jalal SM; Greipp PR
Br J Haematol; 1998 May; 101(2):296-301. PubMed ID: 9609525
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligence.
Abid MB; De Mel S; Abid MA; Tan KB; Chng WJ
Cancer Biol Ther; 2016 Jul; 17(7):723-6. PubMed ID: 27105248
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biological features of t(4;14) multiple myeloma: a prospective study.
Karlin L; Soulier J; Chandesris O; Choquet S; Belhadj K; Macro M; Bouscary D; Porcher R; Ghez D; Malphettes M; Asli B; Brouet JC; Bories JC; Hermine O; Fermand JP; Arnulf B
Leuk Lymphoma; 2011 Feb; 52(2):238-46. PubMed ID: 21261498
[TBL] [Abstract][Full Text] [Related]
16. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.
Han Y; Xue Y; Zhang J; Wu Y; Pan J; Wang Y; Shen J; Dai H; Bai S
Cancer Genet Cytogenet; 2008 Dec; 187(2):125-9. PubMed ID: 19027493
[TBL] [Abstract][Full Text] [Related]
17. Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review.
Manda-Mapalo MT; Khalili P; Quintana D; Rabinowitz I; Zhang QY
Cancer Genet; 2016 Oct; 209(10):481-485. PubMed ID: 27810077
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.
Fonseca R; Hoyer JD; Aguayo P; Jalal SM; Ahmann GJ; Rajkumar SV; Witzig TE; Lacy MQ; Dispenzieri A; Gertz MA; Kyle RA; Greipp PR
Leuk Lymphoma; 1999 Nov; 35(5-6):599-605. PubMed ID: 10609798
[TBL] [Abstract][Full Text] [Related]
19. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
[TBL] [Abstract][Full Text] [Related]
20. A der(22)t(9;22)(p13;q11) in bone marrow cells of a patient with multiple myeloma: a variant of the t(9;14)(p13;q32) associated with a subset of lymphoplasmacytoid lymphoma.
Smadja NV; Grange MJ
Cancer Genet Cytogenet; 1998 May; 103(1):78-80. PubMed ID: 9595053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
